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Abstract:
Organophosphate (OP) chemicals include nerve agents and pesticides, and there is a
growing concern of OP based chemical attacks against civilians. Current antidotes are essential
in limiting immediate mortality associated with OP exposure. However, further research is
needed to identify molecular mechanisms underlying long-term neurological deficits following
survival of OP toxicity in order to develop effective therapeutics. We have developed rat survival
models of OP induced status epilepticus (SE) that mimic chronic mortality and morbidity
following OP intoxication. We have observed significant elevations in hippocampal calcium
levels after OP SE that persisted for weeks following initial survival. Drugs inhibiting
intracellular calcium-induced calcium release such as dantrolene, levetiracetam, and carisbamate
lowered OP-SE mediated protracted calcium elevations. Given the critical role of calcium
signaling in modulating behavior and cell-death mechanisms, drugs targeted at preventing the
development of the calcium plateau could enhance neuroprotection, help reduce morbidity and
improve outcome following survival of OP SE.
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Introduction
The Increasing Risk for Organophosphate Exposure
Organophosphate (OP) chemicals include nerve agents such as Sarin and pesticides such
as Parathion. These compounds are considered extremely lethal. The civilian population has been
exposed to nerve agents under acts of war and terrorism. Recent examples include the reported
2015 Sarin gas attack in Ghouta, Syria 1, the Tokyo sub-way Sarin attack by the “Aum
Shinrikyo” cult in 1995 2, and the 1988 “Halabja chemical attack” against Kurdish people in Iraq
3

. OP based pesticides have also been used against civilians during the Rhodesian War 4 and the

accidental poisoning in Indian children following consumption of pesticide contaminated lunches
5

. In addition, civilians are exposed to OP’s intentionally by suicide attempts or occupationally or

due to industrial accidents. In fact, pesticide ingestion is one of the most common method for
committing suicide in developing nations6, 7 8. The military population has also been exposed to
OP chemicals. Approximately 30% of returning soldiers from the Persian Gulf War suffer from a
cluster of symptoms commonly known as Gulf War Syndrome. Prolonged exposure to OP based
pesticides or exposure to Sarin gas, following demolition of chemical weapon stockpiles are
amongst the possible causes thought to be responsible for this syndrome9-11. The ease of
availability of pesticides make them attractive target to be weaponized and cause mass civilian
causalities. Thus, there is a growing threat of OP toxicity in the current geopolitical environment.
Research in this field has provided therapeutic antidotes that are critical in limiting immediate
mortality associated with lethal OP intoxication 12. However, further research is needed to
identify molecular mechanisms underlying chronic mortality and morbidity in order to develop
effective counteract therapeutics following OP exposure 13.
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Organophosphate Poisoning: Mechanisms, Treatments, and Challenges
Paraoxon (POX) is an active metabolite of parathion and is used in laboratory research to
reliably model OP pesticide toxicity14. Similarly, diisopropyl fluorophosphates (DFP) is used in
civilian research as a nerve agent surrogate to model sarin exposure given the ease of handling
associated with DFP15-18. POX, DFP and other OP chemicals are potent inhibitors of the enzyme
acetylcholinesterase (AChE)19. Inhibition of AChE prevents breakdown of the neurotransmitter
acetylcholine (ACh) and rapidly builds up ACh level at the synapses. Overstimulation of ACh
receptors leads to the classical “cholinergic crisis” characterized by salivation, lacrimation,
urination, and defecation. This is followed by respiratory depression and bradycardia. Nicotinic
receptor stimulation causes muscle fasciculation. This is followed by tonic-clonic seizures and
status epilepticus (SE), or prolonged seizure activity that continues unabated and results in the
death if left untreated 20. SE activity is thought to involve recruitment of N-methyl-D-aspartate
(NMDA) receptors following release of the excitatory neurotransmitter glutamate downstream of
the ACh overstimulation21-24. Current treatment strategies use atropine to control the cholinergic
crisis, pralidoxime, to reactivate AChE, and a benzodiazepine such as diazepam or midazolam to
control seizures 25 26. While the current antidotes are critical in limiting immediate mortality
associated with OP exposure, OP/ SE survivors are vulnerable to delayed mortality in the critical
2-week period post initial survival and the development of chronic neurological morbidities such
as recurrent seizures, depression and cognitive deficits 14, 22, 27-35. Thus, it is essential to develop
valid animal models that mimic OP mortality and morbidity and to identify molecular
mechanisms underlying long-term neurological deficits from survival of OP toxicity in order to
develop effective counteract therapeutics.
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Rat survival models of OP-SE
Many OP studies in literature have focused on effects of low-dose, chronic OP exposure
or effects of OP’s following in-utero exposure36-39. There are also studies reporting models of
acute parathion40, 41 and POX exposures42-44. However, these models did not focus on evaluating
long term survival after lethal POX SE exposures. Development of OP SE models is also
complicated by their variable pharmacokinetic and pharmacodynamics response, such as the
challenges associated with parathion kinetics and differential metabolism45-47. We wanted to
further develop a reliable rat survival model for lethal OP exposure with SE that would replicate
both the acute mortality and chronic morbidity associated with these agents. Such animal models
could be very useful to study molecular mechanisms of OP toxicities and screen medical
countermeasures to improve survival following OP exposures.
To this end we have developed two SE survival models of OP toxicity using lethal doses
of POX 14 and DFP 16. The behavioral manifestations, and EEG profile for these OP SE models
mimicked the signs and symptoms of acute OP intoxication. In this model, rats were exposed to a
lethal dose (approximately 2x LD50) of OP chemical (POX or DFP) and were treated with FDA
approved drugs to limit immediate mortality26. Here we will discuss the POX model of OP-SE.
One week prior to SE experiments, rats were stereotaxically implanted with skull surface
electrodes to record EEG. Briefly, one minute following POX injection (2 mg/kg, s.c.) animals
received human-dose equivalents of 2-PAM (25 mg/kg, i.m.) and atropine (0.5 mg/kg, i.m.).
Within 5-7 minutes following POX administration, rats displayed overt cholinergic symptoms
and rapidly developed convulsions and SE-like activity. Onset of SE was determined by the
presence of continuous class 4-5 level seizures using a modified Racine scale 48. One hour
following onset of POX SE, animals were injected with midazolam (2 mg/kg, i.m.) to terminate
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seizures. Surviving animals were then injected with saline (3cc/animal, i.p.) and fed lactose milk
as part of supportive care and returned to their home cages. Surviving rats were housed
individually in temperature and light controlled vivarium. All the rats were visually monitored
once a week till their use in Ca2+ imaging or behavioral experiments. Chronic mortality (72-h
and beyond) in these models of severe OP intoxication was 18-20%14, 16. These POX and DFP
SE survival models manifested the same degree of delayed mortality and morbidity (see below)
observed in the human OP exposure condition49-53.
Development of “Ca2+ Plateau” following survival from OP-SE
One of the important long-term molecular changes that occurs following the survival of
SE induced by OPs or chemoconvulsants like pilocarpine is the development of sustained
elevations in neuronal calcium levels ([Ca2+]i) known as the “Ca2+ plateau” 14, 16, 54-59. We have
developed methodologies to acutely isolate hippocampal CA1 region neurons from brain slices
using enzymatic and mechanical trituration. Neurons obtained using these methods show
minimal signs of necrosis, exhibit normal electrophysiological membrane properties, and allows
us to study Ca2+ dynamics in the absence of confounding factors such as glial response.
Estimation of neuronal Ca2+ levels have revealed the development of a Ca2+ plateau wherein
hippocampal neurons exhibit significantly elevated Ca2+ levels for weeks after the termination of
POX SE 14 (Fig. 1A). We have previously shown that while the induction of Ca2+ plateau was
NMDA receptor dependent during SE 16, 54, the maintenance of the Ca2+ plateau for several
weeks post-SE was independent of NMDA receptor activation and was mediated by persistent
Ca2+ release from the endoplasmic reticulum through the mechanisms of Ca2+ induced Ca2+
release 56, 57. Indeed, pre-treatment with the NMDA antagonist MK-801 prevented the OP SE
induced elevations in hippocampal Ca2+ levels. However, application of MK-801 was not
6

effective in lowering the elevated Ca2+ in hippocampal neurons isolated from rats 1-h following
SE 16 (Fig. 1B). On the other hand, treatments with dantrolene or levetiracetam or carisbamate,
inhibitors of the Ca2+ induced Ca2+ release mechanisms were able to lower the elevated Ca2+
levels and abolish the Ca2+ plateau post SE 14, 57,60 (Fig. 1C). It is important to note that while
NMDA-R mediated indiscriminant Ca2+ influx turns off after SE is terminated, there remains a
sustained Ca2+ release from ER continues due to a long lasting activation of molecular
components involved in the CICR mechanisms. This is an important aspect of the long lasting
activation of the CICR system. Since Ca2+ ions act as major second messengers in multiple
signaling cascades, the OP SE induced prolonged elevations in [Ca2+]i can trigger
neurodegenerative pathways and mediate pathological synaptic plasticity. These alterations in
Ca2+ dynamics following OP toxicity could therefore underlie the associated neuronal injury and
together they be responsible for the chronic neurological morbidities following OP SE14 survival
(Fig. 4).

Neuronal Injury following OP-SE
Neuronal loss in several brain regions has been observed following SE54, 55, OP SE14, 15
and other chemical threat agents61. We have observed widespread neuronal loss induced by POX
SE.as assessed using the Fluoro Jade (FJC) labeling technique14, 62. FJC-positive staining neurons
were observed within the hippocampus, parietal cortex, and in both amygdala and thalamic
nuclear regions of POX SE rats (Fig. 2). Damages to these critical brain areas have been
implicated in memory impairment, depression, anxiety, epilepsy and other neurological
morbidities27, 63, 64.
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Chronic morbidity following survival from OP-SE
We have also analyzed OP SE survivors in these animal models for the development of
neurological morbidities (Fig. 3). We have observed symptoms of chronic depression and
memory impairments in these OP exposed rats62, 65. OP SE survivors displayed increased
immobility in the Forced Swim Test indicative of despair, reduced sucrose consumption in the
Sucrose Preference Test indicative of anhedonia, and spend less time in the open arm of elevated
plus maze indicative of high anxiety 62, 65. Together, despair, anhedonia, and anxiety constituted
symptoms of depression. In addition, these rats performed poorly in the Novel Object
Recognition task indicative of memory impairment62, 65. Survival from OP SE was also
associated with significant neuronal damage throughout the limbic system, particularly the
hippocampus14, 16. These models provide a reproducible method of mimicking the human
survival of OP toxicity. In addition to lethal OP intoxication, chronic low-dose OP exposures
have also been implicated in long-term neurological morbidities. For example, agricultural
pesticide applicators, and Persian Gulf War veterans suspected of chronic OP exposure exhibit
chronic neurological morbidities such as depression and cognitive impairments33, 66, 67.

Conclusion
Ca2+ ions are second messenger molecules in various signaling cascades that modulate
behavior, memory, and cell death55, 56, 68-72. The development of Ca2+ plateau is therefore a
critical substrate for inducing neuronal damage and triggering many of the long term plasticity
changes following OP-SE induced by brain injury 14, 16, 55, 56. Given the role of Ca2+ induced Ca2+
release mechanisms in the maintenance of Ca2+ plateau, drugs targeting the molecular
components of this signaling mechanisms could prove to be effective agents in extending
neuroprotection following survival from OP-SE. We have demonstrated neuroprotective and
8

antiepileptogenic effects of dantrolene57 and carisbamate73 in an in vitro model of SE induced
acquired epilepsy. The ability of dantrolene, levetiracetam, and carisbamate to reduce or abolish
the Ca2+ plateau could make them attractive neuroprotective adjuvant treatments following OPSE. These agents could also prove beneficial in reducing the chronic neurological morbidities
observed in OP SE survivors. We are actively exploring these possibilities in our laboratories
(Fig. 4).
Despite advances in developing more effective agents for controlling the cholinergic
crisis associated with OP SE, there is a pressing need to develop counteract treatments that
prevent or reduce the high mortality and the chronic morbidity associated with OP SE. This is an
important area of research that has direct translational implications for clinical treatment74, 75.
Development of animal models of OP SE are critical to identifying molecular mechanisms
underlying symptoms of OP toxicity. This knowledge can provide molecular targets that can be
used to develop effective therapies for the treatment of OP SE (Fig. 4). This research indicated
that agents that inhibit Ca2+ induced Ca2+ release and can reduce or prevent the Ca2+ plateau may
be an innovative area for development of medical countermeasures that can lower mortality and
morbidity following SE and OP SE.
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Figure Legends
Figure 1. Development of Ca2+ plateau and it’s mechanism following OP induced SE
A. Hippocampal CA1 [Ca2+]i from age-matched control (white bar) and POX rats were isolated
1-h and 1, 7 and 30 days after SE (black bars). [Ca2+]i in POX-SE rats was significantly higher
than control values at all the time-points and did not return to base-line even at 30-days post SE
(Ca2+ plateau). B. Hippocampal CA1 [Ca2+]i from control rats (white bar), DFP rats (black bar),
and DFP + MK-801 (grey bars) were isolated 1-h after SE. MK-801 pretreatment prevented the
elevations in [Ca2+]i that occur following DFP induced SE. However, MK-801 treatment 1-h
after DFP-induced SE did not significantly affect DFP-SE induced [Ca2+]i elevations. C.
Hippocampal CA1 [Ca2+]i from control rats (white bar), POX rats (black bars), and POX + drugs
(grey bars) were isolated 48-h after SE. [Ca2+]i in neurons isolated from POX-SE rats treated
with either dantrolene (DANT) or levetiracetam (LEV) or carisbamate (CRB) were significantly
lower than POX SE rats (no drugs) values at the respective time point. All data represented as
mean  SEM. *p<0.05 (Data in 1A and 1C reproduced from Deshpande, L.S., D.S. Carter, K.F.
Phillips, et al. 2014. Development of status epilepticus, sustained calcium elevations and
neuronal injury in a rat survival model of lethal paraoxon intoxication. Neurotoxicology. 44C:
17-26).
Figure 2. Neuronal injury following POX induced SE
Representative photomicrographs of Fluoro-Jade C (FJC) staining in the dentate gyrus-hilus
region, parietal cortex, amygdala, and thalamus 2 days after POX SE. Scale bars, 200 μm. (Data
previously published in : Deshpande, L.S., D.S. Carter, K.F. Phillips, et al. 2014. Development
of status epilepticus, sustained calcium elevations and neuronal injury in a rat survival model of
lethal paraoxon intoxication. Neurotoxicology. 44C: 17-26).
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Figure 3. Chronic behavioral morbidities following POX induced SE
Approximately 3-months following POX SE, surviving rats were tested on various behavioral
assays for assessing symptoms of depression and memory impairments. A. Increased immobility
time in POX SE rats during the Forced Swim Test indicative of behavioral despair. B. Decreased
sucrose consumption in POX SE rats on the Sucrose Preference Test indicative of anhedonia
(lack of feeling pleasure). C. Enhanced anxiety in POX SE rats as characterized by significantly
less time spent in the open arm of the Elevated Plus Maze. D. Impaired recognition memory in
POX SE rats on the Novel Object Recognition test as displayed significantly less time spent
exploring the novel object. All data expressed as mean ± SEM, *p<0.05, t-test, n= 8 rats. (Data
adapted from: Deshpande, L.S., K. Phillips, B. Huang, et al. 2014. Chronic behavioral and
cognitive deficits in a rat survival model of paraoxon toxicity. Neurotoxicology. 44: 352-357).
Figure 4. Development of the calcium plateau following OP induced SE and possible targets
for countermeasures therapy
OP chemicals such as DFP or POX inhibit the enzyme acetylcholinesterase (AChE) initially
producing a cholinergic crisis that propagates into self-sustaining SE and ultimately leads to
glutamate excitotoxicity. Downstream activation of N-methyl-D-aspartate receptors (NMDA-R)
leads to massive influx of Ca2+ ions into the post-synaptic neurons. Activation of Ca2+-induced
Ca2+-release (CICR) mechanisms leads to release of Ca2+ into the cytoplasm from the
endoplasmic reticulum (ER) via the ryanodine receptor (RyR) and the inositol-trisphosphate
receptor (IP3R). While NMDA activation is required for genesis of Ca2+ plateau, the maintenance
is dependent on sustained Ca2+ release via CICR mechanisms. After SE is terminated NMDA
activation is shut off, but the Ca2+ release from ER continues due to a long lasting activation of
CICR mechanisms. The Ca2+ plateau triggers neurodegenerative pathways leading to neuronal
17

injury and activates nuclear signaling that can lead to neuronal plasticity that underlies chronic
morbidities characterized by the development of acquired epilepsy, memory deficits, and
psychiatric impairments. Inhibiting the critical targets (1, 2 or 3) in the Ca2+ plateau cascade with
pharmacological agents (Dantrolene, Levetiracetam, or Ketamine) can exert neuroprotective
effects and can decrease or prevent the development of the chronic neurological morbidities
associated with OP SE survival.
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